MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive (loss) income
-$19,578,000
Net (loss) income
-$18,891,000
(-7.00%↓ Y/Y)
Total other
comprehensive loss
-$687,000
Other income, net
$3,295,000
(19.91%↑ Y/Y)
Loss from operations
-$22,186,000
(-8.74%↓ Y/Y)
Unrealized loss on
marketable securities
-$687,000
Total operating
expenses
$22,186,000
(8.74%↑ Y/Y)
Research and development
$14,084,000
(5.07%↑ Y/Y)
General and
administrative
$8,102,000
(15.76%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. (FULC)